NPI: 1366433195 · CANTON, OH 44708 · General Acute Care Hospital · NPI assigned 11/01/2005
Authorized official LARAWAY, DENNIS controls 20+ related entities in our dataset. Read more
| Authorized Official | LARAWAY, DENNIS (EXECUTIVE VP CHIEF FINANCE OFFICER) |
| NPI Enumeration Date | 11/01/2005 |
Other providers sharing the same authorized official: LARAWAY, DENNIS
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 218,914 | $7.02M |
| 2019 | 248,067 | $7.32M |
| 2020 | 162,023 | $7.55M |
| 2021 | 193,391 | $8.95M |
| 2022 | 213,388 | $10.21M |
| 2023 | 633,197 | $28.42M |
| 2024 | 445,364 | $17.51M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 191,373 | 153,053 | $17.85M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 118,442 | 110,278 | $7.87M |
| 96361 | Intravenous infusion, hydration; each additional hour | 20,922 | 14,759 | $6.42M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 49,296 | 40,593 | $6.34M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 48,375 | 42,921 | $5.62M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 42,376 | 39,130 | $4.58M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 43,741 | 40,586 | $4.46M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 39,614 | 37,666 | $2.73M |
| 70450 | Computed tomography, head or brain; without contrast material | 11,337 | 9,335 | $2.67M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 26,704 | 8,115 | $2.01M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 8,569 | 6,614 | $2.01M |
| 41899 | Unlisted procedure, dentoalveolar structures | 1,198 | 929 | $986K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 6,768 | 4,391 | $972K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 7,279 | 5,657 | $883K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 7,782 | 6,898 | $811K |
| 80053 | Comprehensive metabolic panel | 58,537 | 45,930 | $785K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 3,508 | 2,734 | $706K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 3,126 | 1,386 | $659K |
| G0378 | Hospital observation service, per hour | 7,845 | 3,025 | $592K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 2,679 | 1,977 | $530K |
| 80048 | Basic metabolic panel (calcium, ionized) | 65,115 | 53,346 | $521K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 8,020 | 7,479 | $498K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 1,094 | 790 | $461K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 6,874 | 6,405 | $453K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 2,571 | 2,478 | $453K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,493 | 1,070 | $400K |
| 52000 | 668 | 536 | $381K | |
| 62323 | 1,024 | 867 | $363K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1,458 | 1,159 | $356K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 2,773 | 2,052 | $338K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 10,794 | 10,066 | $330K |
| 84443 | Thyroid stimulating hormone (TSH) | 20,302 | 17,683 | $301K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 13,499 | 12,037 | $285K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2,571 | 2,064 | $280K |
| 96127 | 3,954 | 2,923 | $278K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 9,833 | 3,489 | $276K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 97,340 | 78,617 | $267K |
| 80061 | Lipid panel | 23,589 | 21,033 | $260K |
| 20610 | 1,369 | 987 | $213K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 4,845 | 2,185 | $207K |
| D2930 | Prefabricated stainless steel crown - primary tooth | 368 | 71 | $199K |
| 97161 | 3,161 | 2,706 | $191K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1,536 | 634 | $190K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1,721 | 1,316 | $186K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1,508 | 1,158 | $178K |
| 36415 | Collection of venous blood by venipuncture | 155,564 | 117,151 | $174K |
| 70498 | 613 | 460 | $172K | |
| 59025 | Fetal non-stress test | 1,064 | 545 | $169K |
| 83036 | Hemoglobin; glycosylated (A1C) | 12,937 | 11,136 | $165K |
| 93458 | 155 | 95 | $162K | |
| 71046 | Radiologic examination, chest; 2 views | 17,959 | 15,334 | $161K |
| 84484 | 34,838 | 24,961 | $157K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 3,429 | 1,345 | $155K |
| 81003 | 38,381 | 34,844 | $154K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 248 | 216 | $152K |
| 95811 | 225 | 178 | $146K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1,102 | 970 | $139K |
| 70491 | 430 | 320 | $138K | |
| 93975 | 957 | 696 | $137K | |
| 76642 | 1,364 | 919 | $134K | |
| J3490 | Unclassified drugs | 32,396 | 20,010 | $131K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 518 | 442 | $129K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1,437 | 999 | $127K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1,634 | 516 | $125K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 728 | 592 | $123K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 8,998 | 6,985 | $123K |
| 51700 | 484 | 196 | $113K | |
| 96367 | 1,535 | 831 | $110K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 46,096 | 35,863 | $106K |
| 20553 | 836 | 676 | $105K | |
| 90677 | 622 | 473 | $99K | |
| 93017 | 1,199 | 901 | $98K | |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | 454 | 357 | $96K |
| 85027 | 21,444 | 15,729 | $95K | |
| 90839 | 725 | 563 | $90K | |
| 93971 | 2,024 | 1,710 | $89K | |
| 94060 | 915 | 799 | $89K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2,772 | 2,244 | $87K |
| 80076 | 18,258 | 16,387 | $87K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 982 | 396 | $85K |
| 93970 | 1,280 | 1,094 | $85K | |
| 97162 | 1,678 | 1,430 | $81K | |
| 76770 | 521 | 435 | $81K | |
| 84439 | 4,046 | 3,395 | $78K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 463 | 396 | $76K |
| 87081 | 3,380 | 3,290 | $73K | |
| 72100 | 2,376 | 1,934 | $70K | |
| 71250 | 777 | 688 | $69K | |
| 97535 | Self-care/home management training, each 15 minutes | 2,207 | 1,430 | $68K |
| 76536 | 630 | 533 | $67K | |
| 10060 | 385 | 289 | $66K | |
| 82607 | 3,831 | 3,137 | $66K | |
| 76830 | Ultrasound, transvaginal | 1,287 | 971 | $65K |
| 93798 | 1,109 | 182 | $64K | |
| 97113 | 845 | 274 | $63K | |
| 97014 | 1,749 | 601 | $62K | |
| 82728 | 5,195 | 4,295 | $58K | |
| 95886 | 178 | 146 | $57K | |
| 86850 | 2,871 | 2,104 | $56K | |
| 74018 | 2,151 | 1,648 | $54K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 1,090 | 876 | $51K |
| 86140 | 2,979 | 2,366 | $49K | |
| 73564 | 2,425 | 1,883 | $49K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 17,446 | 14,277 | $48K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 233 | 201 | $47K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 354 | 305 | $47K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 20,805 | 14,577 | $46K |
| 12001 | 281 | 223 | $45K | |
| 50590 | 19 | 12 | $45K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 335 | 295 | $44K |
| 97016 | 1,520 | 467 | $43K | |
| 83540 | 5,981 | 4,976 | $42K | |
| 72131 | 430 | 339 | $42K | |
| 94729 | 959 | 848 | $42K | |
| 73630 | 2,974 | 2,263 | $42K | |
| 86803 | 2,349 | 1,921 | $41K | |
| 87070 | 3,270 | 2,731 | $40K | |
| 90715 | 2,551 | 1,811 | $40K | |
| 97165 | 734 | 586 | $40K | |
| 72050 | 960 | 793 | $39K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 230 | 181 | $38K |
| 82805 | 1,444 | 961 | $37K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 6,157 | 4,885 | $37K |
| 73030 | 2,313 | 1,667 | $37K | |
| 86900 | 3,127 | 2,281 | $36K | |
| 97116 | 1,682 | 687 | $34K | |
| 94726 | 633 | 557 | $33K | |
| 73130 | 2,258 | 1,657 | $33K | |
| 83550 | 5,721 | 4,773 | $33K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 316 | 251 | $32K |
| 72125 | Computed tomography, cervical spine; without contrast material | 2,378 | 1,770 | $32K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 791 | 573 | $31K |
| 73610 | 2,533 | 1,948 | $31K | |
| D1110 | Prophylaxis - adult | 571 | 379 | $31K |
| 71045 | Radiologic examination, chest; single view | 10,349 | 8,369 | $30K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2,142 | 1,664 | $30K |
| 83735 | 11,696 | 7,163 | $29K | |
| 97802 | 480 | 376 | $29K | |
| 71271 | 217 | 180 | $29K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 228 | 176 | $29K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 6,165 | 4,889 | $27K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4,696 | 2,439 | $27K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 29,284 | 23,941 | $27K |
| 77080 | 444 | 364 | $27K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 166 | 137 | $27K |
| 84436 | 1,803 | 1,625 | $26K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1,863 | 1,346 | $26K |
| 97166 | 451 | 360 | $25K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 506 | 503 | $25K |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 1,579 | 1,095 | $24K |
| D0120 | Periodic oral evaluation - established patient | 761 | 494 | $21K |
| 70486 | 791 | 595 | $21K | |
| 83992 | 1,631 | 1,485 | $21K | |
| 72110 | 572 | 496 | $21K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 303 | 273 | $20K |
| 73110 | 1,552 | 1,185 | $20K | |
| 84702 | 1,944 | 1,256 | $20K | |
| 85610 | 7,884 | 5,034 | $20K | |
| 73502 | 1,186 | 927 | $20K | |
| 64493 | 40 | 25 | $20K | |
| 80326 | 1,633 | 1,486 | $20K | |
| 72141 | 112 | 101 | $19K | |
| 81001 | 18,345 | 13,360 | $19K | |
| 93799 | 3,891 | 1,119 | $19K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 161 | 129 | $19K |
| 82570 | 2,285 | 1,925 | $18K | |
| 93880 | 229 | 177 | $18K | |
| 80338 | 1,759 | 1,582 | $18K | |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | 334 | 272 | $17K |
| 80370 | 1,758 | 1,583 | $17K | |
| 80373 | 1,759 | 1,583 | $17K | |
| 80355 | 1,760 | 1,583 | $17K | |
| 80367 | 1,759 | 1,583 | $17K | |
| 80372 | 1,758 | 1,582 | $17K | |
| 80366 | 1,758 | 1,582 | $17K | |
| 80368 | 1,758 | 1,582 | $17K | |
| 80357 | 1,758 | 1,582 | $17K | |
| 83970 | 648 | 534 | $17K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4,034 | 3,970 | $17K |
| 12011 | 105 | 81 | $17K | |
| 84153 | 1,545 | 1,283 | $17K | |
| 80331 | 1,633 | 1,486 | $17K | |
| 86038 | 784 | 598 | $16K | |
| 80337 | 1,632 | 1,485 | $16K | |
| 80334 | 1,632 | 1,485 | $16K | |
| 74178 | 71 | 64 | $16K | |
| 99460 | 230 | 207 | $16K | |
| 80377 | 1,633 | 1,486 | $16K | |
| 80341 | 1,633 | 1,486 | $16K | |
| 80344 | 1,632 | 1,485 | $16K | |
| 83880 | 3,187 | 2,365 | $16K | |
| D0274 | Bitewings - four radiographic images | 519 | 347 | $16K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 155 | 125 | $16K |
| 86780 | 1,331 | 1,036 | $16K | |
| 80346 | 1,760 | 1,583 | $16K | |
| 77062 | 455 | 367 | $16K | |
| 80361 | 1,759 | 1,583 | $15K | |
| 80365 | 1,760 | 1,584 | $15K | |
| 80348 | 1,760 | 1,583 | $15K | |
| 80354 | 1,760 | 1,583 | $15K | |
| 80359 | 1,758 | 1,582 | $15K | |
| 80358 | 1,759 | 1,583 | $15K | |
| 77336 | 185 | 81 | $15K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 43 | 42 | $15K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 4,315 | 3,575 | $15K |
| 90688 | 862 | 552 | $15K | |
| 80364 | 1,632 | 1,486 | $14K | |
| 80353 | 1,633 | 1,486 | $14K | |
| 80360 | 1,631 | 1,485 | $14K | |
| 80371 | 1,631 | 1,485 | $14K | |
| 99215 | Prolong outpt/office vis | 150 | 148 | $14K |
| 82043 | 2,464 | 2,082 | $14K | |
| 81002 | 4,105 | 2,754 | $14K | |
| 84481 | 1,284 | 1,072 | $14K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 155 | 109 | $13K |
| 88307 | 98 | 50 | $13K | |
| 99232 | Subsequent hospital care, per day, moderate complexity | 713 | 317 | $13K |
| D7140 | Extraction, erupted tooth or exposed root | 24 | 12 | $13K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2,076 | 1,590 | $13K |
| 12002 | 93 | 63 | $13K | |
| 87340 | 1,050 | 801 | $12K | |
| 19083 | 19 | 14 | $12K | |
| 82962 | 9,218 | 2,824 | $12K | |
| 99406 | 491 | 422 | $12K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 104 | 77 | $12K |
| 97602 | 94 | 49 | $12K | |
| 70496 | 640 | 483 | $11K | |
| 82746 | 1,548 | 1,260 | $11K | |
| 72040 | 373 | 295 | $11K | |
| 80320 | 1,338 | 1,212 | $11K | |
| 72072 | 401 | 342 | $11K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3,743 | 2,579 | $11K |
| 88341 | 166 | 115 | $11K | |
| 97164 | 148 | 118 | $11K | |
| 77061 | 296 | 227 | $10K | |
| 51798 | 2,293 | 1,795 | $10K | |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | 115 | 64 | $10K |
| 83690 | 14,878 | 11,937 | $10K | |
| 73140 | 1,035 | 783 | $10K | |
| 87507 | 109 | 86 | $10K | |
| 77065 | Tomosynthesis, mammo | 634 | 502 | $10K |
| 73221 | 50 | 40 | $10K | |
| 80069 | 527 | 417 | $10K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | 16 | 16 | $10K |
| 90792 | Psychiatric diagnostic evaluation with medical services | 44 | 44 | $9K |
| P9016 | Red blood cells, leukocytes reduced, each unit | 21 | 12 | $9K |
| 96375 | Therapeutic injection; each additional sequential IV push | 17,973 | 13,540 | $9K |
| 86901 | 3,125 | 2,280 | $9K | |
| 49083 | 26 | 13 | $9K | |
| 73560 | 887 | 654 | $9K | |
| 94010 | 114 | 102 | $9K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 17 | 12 | $8K |
| 87077 | 2,567 | 1,984 | $8K | |
| 86706 | 509 | 411 | $8K | |
| J1756 | Injection, iron sucrose, 1 mg | 335 | 111 | $8K |
| 99152 | 1,007 | 710 | $8K | |
| 80197 | 602 | 255 | $8K | |
| D1206 | Topical application of fluoride varnish | 323 | 210 | $8K |
| 82784 | 586 | 433 | $8K | |
| 86762 | 509 | 388 | $8K | |
| 99238 | Hospital discharge day management, 30 minutes or less | 277 | 243 | $8K |
| 84403 | 555 | 427 | $7K | |
| 81025 | 7,675 | 6,013 | $7K | |
| 85652 | 2,139 | 1,518 | $7K | |
| 87522 | Neg quan hep c or qual rna | 395 | 283 | $7K |
| 86431 | 603 | 488 | $7K | |
| 96376 | 4,158 | 1,815 | $7K | |
| 64635 | 19 | 12 | $7K | |
| 93225 | 75 | 54 | $7K | |
| 73590 | 790 | 560 | $7K | |
| 84100 | 1,571 | 844 | $6K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4,317 | 3,421 | $6K |
| 82550 | 2,504 | 1,595 | $6K | |
| 87486 | 166 | 107 | $6K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,839 | 1,314 | $6K |
| 71101 | 545 | 430 | $6K | |
| 76981 | 156 | 126 | $6K | |
| 90686 | 683 | 637 | $6K | |
| 73080 | 624 | 480 | $6K | |
| 62321 | 14 | 12 | $6K | |
| 99223 | Prolong inpt eval add15 m | 92 | 76 | $5K |
| D0140 | Limited oral evaluation - problem focused | 135 | 91 | $5K |
| 80164 | 559 | 439 | $5K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 53 | 51 | $5K |
| 76870 | 184 | 130 | $5K | |
| 87536 | 105 | 74 | $5K | |
| 84550 | 1,014 | 699 | $5K | |
| 84703 | 8,994 | 7,146 | $5K | |
| 64430 | 17 | 12 | $5K | |
| 87430 | 4,299 | 3,416 | $5K | |
| 86480 | 135 | 110 | $5K | |
| 82077 | 5,215 | 3,536 | $5K | |
| 86359 | 73 | 46 | $5K | |
| 86364 | 247 | 176 | $5K | |
| 77066 | Tomosynthesis, mammo | 494 | 405 | $5K |
| 86235 | 292 | 168 | $5K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 65 | 55 | $5K |
| 83615 | 687 | 484 | $4K | |
| 87186 | 2,779 | 2,190 | $4K | |
| 73090 | 550 | 414 | $4K | |
| 86141 | 162 | 141 | $4K | |
| 87640 | 279 | 238 | $4K | |
| 85651 | 867 | 817 | $4K | |
| 88142 | 884 | 756 | $4K | |
| 86703 | 253 | 241 | $4K | |
| 86787 | 337 | 256 | $4K | |
| 93270 | 35 | 25 | $4K | |
| 73700 | 36 | 25 | $4K | |
| H1000 | Prenatal care, at-risk assessment | 57 | 52 | $4K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1,216 | 947 | $4K |
| 91320 | 45 | 45 | $4K | |
| 76801 | 46 | 43 | $3K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 232 | 175 | $3K |
| 82330 | 1,815 | 1,143 | $3K | |
| 84402 | 199 | 155 | $3K | |
| 82670 | 149 | 104 | $3K | |
| 87493 | 225 | 180 | $3K | |
| 96368 | 247 | 149 | $3K | |
| 83605 | 5,594 | 3,475 | $3K | |
| 99153 | Mod sedat endo service >5yrs | 738 | 520 | $3K |
| 97803 | 43 | 40 | $3K | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 420 | 377 | $3K |
| 93296 | 208 | 197 | $3K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 267 | 209 | $3K |
| 80074 | 152 | 95 | $3K | |
| 87210 | 1,140 | 882 | $3K | |
| 84630 | 148 | 110 | $3K | |
| 82565 | 497 | 391 | $3K | |
| 90658 | 336 | 326 | $3K | |
| 73562 | 74 | 67 | $3K | |
| 87497 | 175 | 62 | $3K | |
| 87581 | 165 | 107 | $3K | |
| 88342 | 537 | 366 | $3K | |
| 97035 | 26 | 12 | $3K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 479 | 351 | $3K |
| 82977 | 370 | 203 | $3K | |
| 82947 | 1,562 | 1,096 | $3K | |
| D0220 | Intraoral - periapical first radiographic image | 309 | 195 | $2K |
| 87147 | 1,047 | 734 | $2K | |
| 87641 | 280 | 238 | $2K | |
| 86376 | 123 | 84 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 10,732 | 7,171 | $2K |
| 85379 | 1,789 | 1,301 | $2K | |
| 82533 | 138 | 112 | $2K | |
| 84156 | 607 | 446 | $2K | |
| 85730 | 3,342 | 2,131 | $2K | |
| 74022 | 270 | 194 | $2K | |
| 87040 | 2,468 | 1,080 | $2K | |
| 73552 | 292 | 191 | $2K | |
| 88304 | 469 | 304 | $2K | |
| 82950 | 262 | 210 | $2K | |
| 82140 | 303 | 206 | $2K | |
| 87205 | 1,134 | 907 | $2K | |
| 84480 | 125 | 87 | $2K | |
| 90674 | 91 | 91 | $2K | |
| 80321 | 127 | 97 | $2K | |
| 86160 | 193 | 100 | $2K | |
| 73620 | 66 | 64 | $2K | |
| 83001 | 114 | 94 | $2K | |
| 84132 | 3,154 | 2,192 | $2K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 16 | 16 | $2K |
| 82677 | 57 | 54 | $2K | |
| D1120 | Prophylaxis - child | 70 | 40 | $2K |
| 82105 | 115 | 94 | $2K | |
| 73660 | 162 | 136 | $2K | |
| 86258 | 48 | 25 | $2K | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 669 | 269 | $2K |
| 86200 | 181 | 167 | $2K | |
| J1644 | Injection, heparin sodium, per 1000 units | 4,691 | 1,538 | $2K |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 1,121 | 474 | $2K |
| 84144 | 45 | 26 | $2K | |
| 77334 | 14 | 12 | $2K | |
| 84145 | 1,613 | 1,131 | $2K | |
| 90480 | 45 | 45 | $2K | |
| 82248 | 157 | 91 | $1K | |
| 86704 | 91 | 63 | $1K | |
| 73070 | 79 | 60 | $1K | |
| 82103 | 82 | 46 | $1K | |
| 80333 | 127 | 97 | $1K | |
| 80345 | 127 | 97 | $1K | |
| 85018 | 1,937 | 1,263 | $1K | |
| 95806 | 18 | 15 | $1K | |
| 80363 | 127 | 97 | $1K | |
| Q3014 | Telehealth originating site facility fee | 723 | 652 | $1K |
| 96523 | 24 | 24 | $1K | |
| 87905 | 1,137 | 918 | $1K | |
| 84134 | 102 | 83 | $1K | |
| 99233 | Prolong inpt eval add15 m | 53 | 19 | $1K |
| 73060 | 121 | 95 | $1K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 369 | 248 | $1K |
| D0330 | Panoramic radiographic image | 19 | 18 | $1K |
| 83002 | 92 | 72 | $1K | |
| 83520 | 57 | 54 | $1K | |
| 85045 | 824 | 699 | $1K | |
| 76857 | 54 | 52 | $1K | |
| 84450 | 1,189 | 859 | $1K | |
| 99201 | 12 | 12 | $1K | |
| 72170 | 320 | 254 | $1K | |
| 82951 | 68 | 67 | $998.82 | |
| 99442 | 27 | 27 | $981.79 | |
| 99441 | 87 | 82 | $979.08 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 14,074 | 10,765 | $913.99 |
| D0150 | Comprehensive oral evaluation - new or established patient | 18 | 17 | $906.30 |
| 86618 | 172 | 139 | $898.94 | |
| 86225 | 88 | 79 | $873.87 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 2,820 | 2,174 | $872.78 |
| 83020 | 106 | 79 | $865.43 | |
| 99239 | Hospital discharge day management, more than 30 minutes | 27 | 24 | $860.68 |
| 88312 | 16 | 16 | $845.31 | |
| 86308 | 162 | 124 | $843.87 | |
| J3486 | Injection, ziprasidone mesylate, 10 mg | 45 | 27 | $832.69 |
| 82247 | 51 | 25 | $829.56 | |
| J1815 | Injection, insulin, per 5 units | 156 | 108 | $821.84 |
| 84425 | 55 | 41 | $798.71 | |
| 84165 | 85 | 66 | $773.49 | |
| 80336 | 71 | 56 | $771.98 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 1,060 | 343 | $770.23 |
| 77002 | 13 | 12 | $765.63 | |
| 97163 | 14 | 12 | $761.61 | |
| 85014 | 173 | 106 | $744.76 | |
| 81374 | 15 | 15 | $709.19 | |
| 86039 | 70 | 68 | $708.37 | |
| 83525 | 28 | 13 | $697.08 | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 1,389 | 1,068 | $690.22 |
| 90662 | 127 | 112 | $684.57 | |
| 72202 | 27 | 26 | $682.75 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 1,751 | 897 | $679.59 |
| 86003 | 42 | 25 | $651.82 | |
| 73120 | 21 | 21 | $647.98 | |
| 93246 | 12 | 12 | $638.74 | |
| 84520 | 424 | 310 | $635.96 | |
| 99222 | Initial hospital care, per day, moderate complexity | 17 | 14 | $632.33 |
| 76819 | Fetal biophysical profile; without non-stress testing | 18 | 12 | $617.59 |
| 72070 | 41 | 40 | $613.09 | |
| 87808 | 1,143 | 913 | $611.02 | |
| 84460 | 149 | 95 | $597.01 | |
| 82375 | 1,453 | 973 | $591.29 | |
| 76775 | 20 | 13 | $583.38 | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 12 | 12 | $580.38 |
| 84155 | 118 | 79 | $559.24 | |
| 80177 | 45 | 41 | $548.96 | |
| J2469 | Injection, palonosetron hcl, 25 mcg | 197 | 77 | $539.08 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 19,206 | 16,497 | $504.60 |
| D0230 | Intraoral - periapical each additional radiographic image | 117 | 25 | $501.22 |
| 84146 | 72 | 64 | $467.26 | |
| 92610 | 16 | 14 | $451.36 | |
| 84295 | 1,392 | 962 | $449.97 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 1,574 | 887 | $449.60 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 26,094 | 19,015 | $449.58 |
| 76000 | 12 | 12 | $448.53 | |
| 80143 | 741 | 553 | $446.73 | |
| 76820 | 22 | 15 | $438.60 | |
| 87088 | 242 | 237 | $438.29 | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 1,103 | 798 | $433.33 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 297 | 222 | $430.59 |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 57 | 57 | $414.89 |
| 80047 | 176 | 132 | $413.78 | |
| C9113 | Injection, pantoprazole sodium, per vial | 755 | 345 | $379.69 |
| 83655 | 12 | 12 | $372.14 | |
| 00840 | 43 | 20 | $359.56 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 877 | 523 | $353.92 |
| 82378 | 18 | 13 | $339.72 | |
| 83050 | 1,457 | 967 | $338.92 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 683 | 481 | $327.33 |
| 86256 | 21 | 13 | $320.95 | |
| 87102 | 603 | 457 | $312.76 | |
| 93283 | 17 | 12 | $307.49 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 13,521 | 10,550 | $298.17 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 4,785 | 3,646 | $289.20 |
| 86360 | 12 | 12 | $281.18 | |
| 93280 | 47 | 40 | $280.34 | |
| 80179 | 703 | 528 | $263.85 | |
| 83021 | 16 | 15 | $233.03 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 3,221 | 1,639 | $232.83 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 320 | 184 | $230.81 |
| 84590 | 20 | 12 | $229.05 | |
| 94760 | 1,975 | 1,217 | $215.89 | |
| 84479 | 39 | 33 | $201.27 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 1,547 | 1,377 | $200.04 |
| 80335 | 18 | 13 | $199.30 | |
| J2310 | Injection, naloxone hydrochloride, per 1 mg | 23 | 12 | $189.21 |
| 82150 | 41 | 29 | $187.46 | |
| 82040 | 16 | 12 | $186.10 | |
| 85380 | 14 | 13 | $175.58 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 475 | 342 | $156.30 |
| 84478 | 62 | 39 | $143.16 | |
| 90656 | 17 | 17 | $140.74 | |
| J2704 | Injection, propofol, 10 mg | 5,408 | 3,660 | $138.79 |
| J1790 | Injection, droperidol, up to 5 mg | 921 | 579 | $137.94 |
| 70320 | 460 | 416 | $125.25 | |
| J1953 | Injection, levetiracetam, 10 mg | 27 | 13 | $124.19 |
| J0690 | Injection, cefazolin sodium, 500 mg | 2,951 | 1,664 | $123.43 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 5,809 | 4,027 | $111.17 |
| 90694 | 12 | 12 | $105.03 | |
| J2060 | Injection, lorazepam, 2 mg | 857 | 548 | $102.03 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 6,242 | 4,098 | $93.38 |
| J3370 | Injection, vancomycin hcl, 500 mg | 350 | 155 | $89.94 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 7,121 | 4,188 | $89.49 |
| G0008 | Administration of influenza virus vaccine | 326 | 286 | $76.99 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 2,154 | 1,283 | $66.58 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 293 | 284 | $66.31 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 2,444 | 1,623 | $64.41 |
| J2785 | Injection, regadenoson, 0.1 mg | 748 | 544 | $60.58 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 1,177 | 710 | $55.42 |
| 82948 | 47 | 36 | $52.92 | |
| 87653 | 14 | 14 | $41.20 | |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 265 | 117 | $36.28 |
| J1920 | Injection, labetalol hydrochloride, 5 mg | 105 | 82 | $35.77 |
| J1940 | Injection, furosemide, up to 20 mg | 137 | 53 | $35.59 |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 21 | 20 | $33.79 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 881 | 441 | $33.29 |
| 82270 | 12 | 12 | $31.77 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 687 | 479 | $31.57 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 3,376 | 2,388 | $30.14 |
| J3480 | Injection, potassium chloride, per 2 meq | 223 | 132 | $29.45 |
| A4649 | Surgical supply; miscellaneous | 3,917 | 3,705 | $26.79 |
| 82465 | 33 | 26 | $25.17 | |
| 85041 | 20 | 17 | $25.01 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 685 | 509 | $23.93 |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | 83 | 42 | $21.40 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 302 | 214 | $21.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 97 | 74 | $20.63 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 376 | 208 | $20.51 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 1,015 | 858 | $17.66 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 779 | 502 | $15.84 |
| 82010 | 124 | 79 | $15.15 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 50 | 13 | $12.60 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 589 | 467 | $10.66 |
| C1765 | Adhesion barrier | 16 | 14 | $9.51 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 81 | 52 | $7.23 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 33 | 31 | $6.29 |
| J7050 | Infusion, normal saline solution, 250 cc | 2,157 | 1,057 | $6.04 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 118 | 79 | $5.28 |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 66 | 58 | $5.04 |
| J1171 | Injection, hydromorphone, 0.1 mg | 106 | 70 | $4.95 |
| J7030 | Infusion, normal saline solution , 1000 cc | 791 | 501 | $2.54 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 38 | 14 | $2.26 |
| J1630 | Injection, haloperidol, up to 5 mg | 14 | 13 | $2.09 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 562 | 420 | $1.68 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 209 | 181 | $1.30 |
| A6449 | Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard | 14 | 14 | $1.29 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 92 | 82 | $1.03 |
| A9270 | Non-covered item or service | 2,072 | 1,131 | $0.77 |
| 36591 | 44 | 26 | $0.48 | |
| 3078F | 8,670 | 7,650 | $0.00 | |
| 00811 | 141 | 95 | $0.00 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 101 | 89 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 295 | 265 | $0.00 |
| 00400 | 17 | 12 | $0.00 | |
| 3077F | 3,371 | 2,989 | $0.00 | |
| Q9958 | High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml | 269 | 228 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 363 | 249 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 65 | 65 | $0.00 |
| 96417 | 126 | 41 | $0.00 | |
| 90461 | 19 | 13 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 13 | 13 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 608 | 431 | $0.00 |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 18 | 14 | $0.00 |
| C1729 | Catheter, drainage | 53 | 24 | $0.00 |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 15 | 15 | $0.00 |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 36 | 25 | $0.00 |
| J0688 | Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg | 25 | 14 | $0.00 |
| 3075F | 2,259 | 2,004 | $0.00 | |
| 3080F | 2,223 | 1,952 | $0.00 | |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 185 | 177 | $0.00 |
| 3079F | 4,889 | 4,446 | $0.00 | |
| 3074F | 10,475 | 9,343 | $0.00 | |
| A4648 | Tissue marker, implantable, any type, each | 77 | 57 | $0.00 |
| C1769 | Guide wire | 868 | 634 | $0.00 |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | 252 | 172 | $0.00 |
| G0009 | Administration of pneumococcal vaccine | 39 | 25 | $0.00 |
| 94761 | 78 | 70 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 166 | 125 | $0.00 |
| 64494 | 27 | 12 | $0.00 |